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BACKGROUND: Thrombolytic therapy and percutaneous coronary intervention (PCI) 
are effective means to achieve reperfusion in ST-elevation myocardial infarction 
(STEMI), but current trends favour primary PCI. However, there seems to be con-
siderable international and national differences in the management of patients with 
STEMI. Pertinent epidemiological data for Greece are lacking. Thus, the aim of this 
pilot study was to investigate the current implementation of reperfusion strategies in 
North-Western (NW) Greece.
PATIENTS AND METHODS: The region of NW Greece is populated by 600,000 inhabit-
ants, and is served by 6 district hospitals, and 1 tertiary university hospital, the only 
one offering PCI, but not on a 24-hour basis. Thus, the most prevalent reperfusion 
strategy in our region is thrombolytic therapy. The present study was a prospective 
population-based survey conducted over a 5-month period. Sources of data included 
cardiology departments, coronary care units, and intensive care departments located 
in the area.
RESULTS: The total study population consisted of 170 consecutive patients (135 men) 
with a mean age of 67 years, divided into three groups according to time between 
symptom onset and presentation: 99 patients (58.2%) presented within 3 hours (group 
I), 23 (13.5%) between 3-12 hours (Group II), and 48 (28.2%) after 12 hours (Group 
III).
In group I, thrombolysis was performed in 78 (78.7%), primary PCI in 8 (8%) and res-
cue PCI in 6 (6%); 93 patients (94%) were subjected to elective coronary angiography 
and subsequently 38 (40.8%) had elective PCI, 4 (4.3%) coronary artery bypass graft-
ing (CABG), and 51 (54.8%) were managed medically. In group II, thrombolysis was 
given in 17 (73.9%), and rescue PCI in 2 (8.6%) patients; all patients (100%) were sub-
jected to elective coronary angiography and subsequently 10 (43.4%) to elective PCI, 
and 1 (4.3%) to CABG. In group III, thrombolysis was performed in 4 (8.3%), and 
rescue PCI in 1 (2.1%) patient; 42 (87.5%) patients were subjected to elective coronary 
angiography and subsequently 11 (22.9%) had elective PCI, and 8 (16.6%) CABG.
CONCLUSION: A large proportion of patients with STEMI arrive late, but reperfu-
sion therapy is sufficiently implemented in NW Greece. The goal of 75% is certainly 
attainable. Organizing networks of reperfusion at regional level can help to improve 
the rate of reperfusion therapy. Finally, the option of next-day PCI after successful 
thrombolysis is gaining wider acceptance.
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I N T R O D U C T I O N
The primary goal of therapy for acute ST-elevation myo-
cardial infarction (STEMI) is rapid, complete and sustained 
restoration of the infarct-related coronary artery blood flow 
and myocardial perfusion, with a consequent positive impact 
on the patient’s outcome.1-14 Timely reperfusion of the infarct-
related artery is the cornerstone of therapy for this goal.
Thrombolytic therapy and percutaneous coronary inter-
vention (PCI) are effective means to achieve reperfusion, but 
current trends reflect an increasing preference for PCI.1,8,9 
However, there seems to be considerable international and 
national differences in the management of the STEMI popula-
tion.1-9 Pertinent epidemiological data for Greece are lacking. 
Thus, the aim of our pilot study was to investigate the current 
implementation of reperfusion strategies in North-Western 
(NW) Greece.
P A T I E N T S  A N D  M E T H O D S
T H E  G R E E K  C O H O R T
The region of NW Greece, an isolated area with 600,000 
inhabitants, is served by 6 General District Hospitals, and 1 
Tertiary – University Hospital having cardiac catheterization 
laboratory with PCI facilities. Primary PCI cannot be imple-
mented as a routine treatment option in our region since there 
is no experienced staff on-call available on a 7-day/24-hour 
basis. Because the catheterization laboratory during daytime is 
busy with elective cases it is difficult to accommodate STEMI 
patients for primary PCI. For the time being only patients in 
real and urgent need for PCI, such as those who are hemo-
dynamically compromised and hypotensive, young patients 
with large infarcts or with contraindication to fibrinolysis 
can undergo primary PCI, as there is no policy of prehospital 
thrombolysis or of facilitated PCI. Thus, the most prevalent 
reperfusion strategy in our region is thrombolytic therapy.
The present study was a prospective population-based 
survey conducted over a 5-month period. Sources of data 
included cardiology departments, coronary care units, and 
intensive care departments located in the area.
R E S U L T S
The total study population consisted of 170 consecutive 
patients (135 men, 35 women) with a mean age of 67 years. For 
all hospitals the current policy is to thrombolyse patients with 
STEMI and transfer only for rescue PCI. They were divided 
into three groups according to time between symptom onset 
and presentation to the hospital. Ninety nine patients (58.2%, 
76 men, 23 women, mean age 62 years) presented to the ad-
mitting hospitals within 3 hours after the onset of symptoms 
(Group I), 23 (13.5%, 17 men, 6 women, mean age 69.5 years) 
between 3 and 12 hours (Group II), and 48 (28.2%, 42 men, 6 
women, mean age 68.2 years) after 12 hours (Group III).
In the first group of patients, thrombolysis was performed 
in 78 (78.7%), primary PCI in 8 (8%) and rescue PCI in 6 
(6%). Ninety three patients (94%) were subjected to elective 
coronary angiography and subsequently 38 (40.8%) of them 
to elective PCI, 4 (4.3%) to coronary artery bypass grafting 
(CABG), and 51 (54.8%) were managed conservatively.
In the second group (3-12 hours), thrombolysis was per-
formed in 17 (73.9%), and rescue PCI in 2 (8.6%) patients, 
while no patient was subjected to primary PCI. All patients 
(100%) were subjected to elective coronary angiography and 
subsequently 10 (43.4%) of them to elective PCI, 1 (4.3%) to 
CABG, and 12 (52.1%) were managed conservatively.
Finally, in the third group (>12 h), thrombolysis was admin-
istered in 4 (8.3%), and rescue PCI in 1 (2.1%) patient, while 
no patient was subjected to primary PCI. Forty-two (87.5%) 
patients were subjected to elective coronary angiography and 
subsequently 11 (22.9%) of them to elective PCI, 8 (16.6%) to 
CABG, and 29 (60.4%) were managed conservatively.
D I S C U S S I O N
Our preliminary results show that at first the main reason 
for no reperfusion was the delayed presentation (>12 hours) 
of a substantial number of patients. Second, the main objec-
tive to achieve at least 75% of reperfusion therapy within the 
shortest possible time following onset of symptoms had been 
reached. The vast majority of patients with STEMI presenting 
within 3 hours and less often within 12 hours after the onset 
of symptoms was offered a reperfusion treatment, mainly 
thrombolysis. The length of prehospital delay was inversely 
proportional to the receipt of fibrinolytic therapy, with over 
86% of patients who presented within 3 hours after the onset 
of symptoms receiving reperfusion therapy and just over 74% 
who presented between 3 and 12 hours after symptom onset. 
There is of course significant room for improvement in pa-
tients who present between 3 and 12 hours with the option of 
performing more frequently primary PCI. Finally the current 
practice in our region is to refer almost all patients for elective 
coronary angiography in a relatively long time interval (usu-
ally 2-7 days post-admission). Subsequently, a considerable 
proportion of those patients are offered a revascularization 
treatment without having undergone non-invasive tests for 
myocardial ischemia.
Even though the development of reperfusion strategies and 
ancillary therapies over the last decades resulted in significant 
improvement in the prognosis of STEMI, the implementa-
tion of such therapies in the ‘real world’ is often inefficient.1-9 
Despite the increasing use of primary PCI, the proportion 
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of eligible patients undergoing early reperfusion remained 
constant at about 70%, from 1994 through 1999, with roughly 
30% of patients receiving neither reperfusion therapy. Find-
ings from the GRACE7 study showed that nearly one –third of 
patients who presented with STEMI within 12 hours and who 
were eligible for reperfusion therapy did not receive it. Thus, a 
considerable proportion of patients with STEMI do not receive 
reperfusion therapy for a variety of reasons. These include age, 
gender, concomitant comorbid conditions, delays in seeking 
medical attention, disparities in health system organization, 
‘triaging’ problems, disparities in patients’ transfer, awareness 
of the public, and other reasons.
On the other hand, when primary PCI is available in a 
“timely” fashion and the procedure can be performed by an 
experienced operator in a large volume center, PCI should 
be considered the preferred reperfusion strategy. However, 
one of the biggest remaining problems is that this strategy is 
vastly underutilized.1 The majority of patients with STEMI 
are admitted to local hospitals without primary PCI facili-
ties.2-7 Access to early angiography is limited in most coun-
tries around the world and in many regions of the US. Data 
from recent registries have shown that approximately 60% 
of patients with high risk acute coronary syndromes undergo 
angiography, of whom approximately 2/3 undergo revascu-
larization (based on the anatomy). Furthermore, only about 
40-45% of patients undergo angiography within the first 48 
hours after admission.
The European Society of Cardiology (ESC) guidelines1 
on PCI offer interventional cardiologists a guide to decision 
–making when choosing the optimal time course and type of 
intervention for patients presenting with STEMI, with the aim 
of maximizing patient outcome and reducing mortality (Fig. 
1). Of the two methods of reperfusion therapy of STEMI, PCI 
is more difficult to implement but offers the best results when 
performed in an optimal setting.
According to current guidelines, reperfusion therapy 
should be commenced in all patients presenting with STEMI 
within 12 hours after the onset of symptoms. For those pre-
senting in a hospital without a PCI facility within 3 hours after 
the onset of symptoms, fibrinolysis is an acceptable option of 
reperfusion therapy. After 3 hours following onset of symp-
toms, primary PCI is strongly favoured by all guidelines. The 
strategy of choice for patients admitted more than 6 hours after 
symptom onset is definitely emergency catheterization because 
many of them will probably receive more harm than good from 
fibrinolysis, especially if their chest pain has subsided. In such 
patients further delay due to transportation to another site 
seems to be justified because myocardial salvage is minimal 
in this late phase and the ultimate goal is sustained patency of 
the infarct related artery and risk assessment. If primary PCI is 
not available, patients admitted approximately 6-12 hours after 
symptom onset who have ongoing chest pain and persistent 
ST-segment elevation may also be considered for fibrinolysis 
as a last chance of reperfusion.10 There is no evidence that 
FIGURE 1. Flow chart of the treatment strategy for patients with STEMI.
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fibrinolysis offers any benefit after 12 hours, possibly because 
it does not restore artery patency. Early PCI is also optimal 
but, in contrast to thrombolysis, revascularization after 12 
hours with PCI may be of some benefit. Primary PCI is also 
preferred for patients presenting with cardiogenic shock and 
for those with contraindications to thrombolysis, regardless of 
the time from symptom onset. Moreover, in the case of failed 
thrombolysis, rescue PCI should be immediately performed.4 
Even in the case of successful thrombolysis, if it is feasible, 
the patient should be transferred for post-thrombolysis PCI 
within the first 24 hours post-admission.11,13
C O N C L U S I O N S
We conclude that a large proportion of patients arrive late, 
but reperfusion therapy is sufficiently implemented in NW 
Greece. The goal of 75% is certainly attainable. Organizing 
networks of reperfusion at regional level based on a clear 
common protocol, can help to improve the rate of reperfusion 
therapy. Special attention should be paid to next-day PCI after 
successful thrombolysis, since it has been proven efficacious. 
Public information campaigns should be considered, as most 
of the time delay between onset of symptoms and start of 
reperfusion therapy is the delay in patients seeking medical 
attention.
In Greece no special funding exists for primary angioplasty 
and thrombolysis in the hospital remains the standard treat-
ment. Things may be about to change, however, even though 
such a service would require enormous reorganization of 
services and considerable additional investment. Patients with 
acute myocardial infarction would bypass their local hospitals 
and go to specialized centers providing a 24-hour angioplasty 
service. This proposal entails daunting logistical and financial 
challenges, and the prospect of large numbers of emergency 
procedures, many of them performed out of regular working 
hours, raises questions about the quality of such a service.
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